Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important

被引：1
|
作者：
Markopoulos, Christos [1 ]
机构：
[1] Univ Athens, Dept Surg, Sch Med, Athens 11521, Greece
来源：
BREAST CANCER RESEARCH | 2010年 / 12卷 / 04期
关键词：
PREVENTION;
D O I：
10.1186/bcr2609
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Managing bone health in women with breast cancer under adjuvant treatment with aromatase inhibitors: pretreatment bone mineral density is important
    Christos Markopoulos
    Breast Cancer Research, 12
  • [2] Bone mineral density in women with breast cancer and the impact of aromatase inhibitors
    Saleh, B.
    Gronland, N.
    Singer, J.
    Bradpiece, H.
    Patel, A.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : 384 - 385
  • [3] Impact of adjuvant aromatase inhibitors on bone mineral density in breast cancer patients
    Lai, C. N.
    Correa, P. D.
    Alhasso, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition
    Van Poznak, Catherine
    BREAST CANCER RESEARCH, 2010, 12 (03):
  • [5] Managing bone mineral density with oral bisphosphonate therapy in women with breast cancer receiving adjuvant aromatase inhibition
    Catherine Van Poznak
    Breast Cancer Research, 12
  • [6] IMPACT OF CHEMOTHERAPY ON BONE MINERAL DENSITY IN POSTMENOPATHIC WOMEN WITH BREAST CANCER IN TREATMENT WITH AROMATASE INHIBITORS
    Loarce-Martos, J.
    Sifuentes Giraldo, W. A.
    Maldonado Romero, L. V.
    Ahijon Lana, M.
    Velazquez Arce, C.
    Martinez Janez, N.
    Vazquez Diaz, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 698 - 698
  • [7] Aromatase inhibitors and bone health in women with breast cancer
    Chien, Amy Jo
    Goss, Paul E.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (33) : 5305 - 5312
  • [8] Efficacy of denosumab for restoring normal bone mineral density in women receiving adjuvant aromatase inhibitors for early breast cancer
    Sakaguchi, Koichi
    Ono, Hisako
    Nakatsukasa, Katsuhiko
    Ishikawa, Takashi
    Hasegawa, Yoshie
    Takahashi, Masato
    Niikura, Naoki
    Koizumi, Kei
    Sakurai, Teruhisa
    Shigematsu, Hideo
    Takahashi, Shunji
    Taira, Shinichiro
    Suzuki, Masato
    Narui, Kazutaka
    Miura, Daishu
    Yamada, Kimito
    Yoshimura, Mana
    Shioya, Hisashi
    Konishi, Eiichi
    Isao, Yokota
    Imai, Kojiro
    Fujikawa, Kei
    Taguchi, Tetsuya
    MEDICINE, 2019, 98 (32)
  • [9] EFFECT OF AROMATASE INHIBITORS ON BONE MINERAL DENSITY IN PATIENTS WITH BREAST CANCER
    Khachidze, N.
    Giorgadze, E.
    Tsagareli, M.
    Dolidze, N.
    Sharikadze, N.
    Sulikashvili, T.
    Jeiranashvili, N.
    OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S237 - S238
  • [10] Changes in bone mineral density after adjuvant aromatase inhibitors and fracture risk in breast cancer patients
    Berruti, Alfredo
    Tucci, Marcello
    Mosca, Alessandra
    Vana, Federica
    Ardine, Mara
    Dogliotti, Luigi
    Angeli, Alberto
    Bertoldo, Francesco
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (11) : 1455 - 1456
12345